Fig. 6

Effects of PCSK9 inhibition or statin administration on NLRP3 activity in HFD mouse lungs. Representative photomicrographs of caspase-1- and NLRP3- positive areas (A) in lung sections from mice of the different treatment groups are shown (50×). Quantification of NLRP3- (B) and caspase-1-(C) positive areas was performed using an image analysis system. Quantitative RT-PCR measurement of NLRP3 (D), ASC (E), caspase-1 (F), and IL-1β (G) mRNA expression in the lungs is shown. The results are expressed as the mean ± SEM (n = 6 per group). Statistical analysis was performed using one-way ANOVA with Bonferroni correction. *: P < 0.05, **: P < 0.01, and ***: P < 0.001